Biophan Techs Inc (BIPH) 0.0007 $BIPH
Advances in MRI System Market 2013-2018: Architecture, Field Strengths, Technology & Applications in Medical Diagnostics with Market Landscape Analysis
M2 - Tue Aug 19, 6:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xpmg9p/advances_in) has announced the addition of the "Advances in Magnetic Resonance Imaging (MRI) System Market (2013-2018) - Technology Trend Analysis - By Architecture, Field Strengths, Technology & Applications in Medical Diagnostics with Market Landscape Analysis - Estimates up to 2018" report to their offering. The global MR Imaging market is estimated to be $4.13 billion, as of March 2013; it is poised to grow at a CAGR of 4.56% to reach approximately around $5.24 billion by 2018 This market research report evaluates the global market of magnetic resonance imaging by architecture, field strength, technology, application, and geography. The market by architecture is further categorized as closed and open MRI systems; the field strength segment comprises low to mid-field strength, high field strength and very-high field strength MR systems, while the technology segment is classified as MR Angiogram, MR Venogram, functional MRI, MR Spectroscopy and Fusion MR. In addition, the application segment covers breast MRI, cardiac MRI, interventional MRI, whole body MRI and MRI for brain, and neurological disorders. This research report covers in-depth market analysis of MR imaging based on architecture - open and closed systems providing market dynamics and opportunities for the coming five years. Closed systems account for the largest share of the total market in 2013. However open MR systems are anticipated to witness a high growth rate owing to rising demand by physician for claustrophobic and elder patients. The increasing applications in the field of angiography, cancer screening, breast screening, and neurology would certainly foster the growth of the market. Functional MRI remains a significant market, due to increasing number of research to study the human brain and brain disorders across the universities world-wide. Key players in the market include GE Healthcare (U.K.), Hitachi Medical Systems (Japan), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), and Toshiba Medical Systems (Japan). The report profiles around 22 companies - leading magnet systems and RF coil manufacturers to clinical OEMs. Scope of the Report By Architecture - Closed systems - Open systems By Field Strength - Low field strength systems - Mid field strength systems - High field strength systems By Technology - MR Angiogram - MR Venogram - Functional MRI - MR Spectroscopy - Others -Fusion MR By Application - Whole Body MRI systems - Interventional MRI systems - MRI for Brain and Neurological disorder - Breast MRI systems - Cardiac MRI systems - MR systems for Other applications such as -;Chest,Neck, Upper and Lower extremities Companies Featured - Advanced Imaging Research, Inc. DBA Sree Medical Systems - Agilent Technologies, Inc. - ASG Superconductors S.P.A. - Aurora Imaging Technology - Bartington Instruments, Ltd. - Bayer Healthcare Pharmaceuticals - Biophan Technologies, Inc. - Bruker Biospin Gmbh - Doty Scientific, Inc. - Esaote S.P.A - Fonar Corporation - Ge Healthcare - Hitachi Medical Corporation - IMRIs, Inc. - Insightec Ltd. - LMT Lammers Medical Technology Gmbh - MR Instruments, Inc. - Philips Healthcare - Shenzhen Basda Medical Apparatus Co. Ltd. - Siemens Healthcare - Time Medical Systems - Toshiba Medical Systems Corporation For more information visit http://www.researchandmarkets.com/research/xp...dvances_in
A: 41.57 (+0.12), IMRS: 0.22 (-0.05)
Peripheral Vascular Devices - Global Trends, Estimates and Forecasts, 2012-2018
M2 - Tue Aug 05, 4:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/34vckj/peripheral) has announced the addition of the "Peripheral Vascular Devices - Global Trends, Estimates and Forecasts, 2012-2018" report to their offering. Global Peripheral Vascular Devices sector forecasts to reach US$5 billion by 2016 at a CAGR of 10.8% during the analysis period 2012-2018. North American region accounts for highest percentage approximately 42% (2015) of global share while Europe follows next with nearly 27.7% (2018) of the market. Asia-Pacific is the fastest growing region with a CAGR of 12.5% driving a market value of US$1 billion by 2015. On a global scale, projections for Peripheral Vascular Stents market value indicate nearly 36% by 2015 leaving the rest of the market to the Vascular Closure Devices, AAA Stent Grafts, Inferior Vena Cava (IVC) Filters)etc. Geographical analysis for Peripheral Guidewires market shows that the highest Compounded Annual Growth Rate (CAGR) of 13.8% is anticipated from Asia-Pacific region during the analysis period 2012-2018. Europe follows Asia-Pacific with a CAGR of 12.7% while the North America forecasts to drive with a growth rate of 10.8%. Companies Mentioned: - Abbott Vascular Devices - Abiomed, Inc. - Accellent, Inc. - Accutech, Llc - Advansource Biomaterials Corporation - Aerotel Medical Systems, Ltd. - Alere, Inc. - All Pro Corporation - Ambu A/S - Angiodynamics, Inc. - Aortech International, Plc. - Apc Cardiovascular, Ltd. - Aptus Endosystems, Inc. - Arterial Remodeling Technologiesuscome Limited - Asahi Intecc Co., Ltd. - Asahi Kasei Corporation - Ash Access Technology, Inc. - Asian Heart Institute - Atcor Medical Holdings Limited - Atricure, Inc. - Atrium Medical Corporation - Baxter International Inc. - Becton, Dickinson & Co. - Beijing Anzhen Hospital - Berlin Heart Gmbh - Bioclinica - Bioheart, Inc. - Biophan Technologies, Inc. - Biosense Webster, Inc. - Dr?ger Medical Ag & Co. Kg - Edwards Lifesciences, Llc. - Endologix Incorporated - Esaote S.P.A - Fleming Medical Limited - Fluxion - Fudan University Zhongshan Hospital - Fukuda Denshi Co., Ltd. - Gamida Cell Ltd. - Ge Healthcare - Goodman Co., Ltd. - Greatbatch, Inc. - Heartware Ltd. - Hospira, Inc. - Volcano Corporation - 3M Healthcare For more information visit http://www.researchandmarkets.com/research/34vckj/peripheral
BDX: 129.20 (-0.11), GB: 49.57 (-0.10), EW: 124.50 (-0.05), ALR: 40.00 (-0.01), ELGX: 11.48 (-0.21), BAX: 71.75 (-0.33), VOLC: 10.92 (+0.13)
Magnetic Resonance Imaging (MRI) System Advances Market Forecasts & Opportunities, 2018
M2 - Tue Mar 25, 10:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dgsl45/advances_in) has announced the addition of the "Magnetic Resonance Imaging (MRI) System Advances Market Forecasts & Opportunities, 2018" report to their offering. The global market for these systems values $4.13 billion, as of the first quarter of 2013, and is expected to grow at a CAGR of 4.56% reaching approximately around $5.24 billion by 2018 The current magnetic resonance imaging industry is producing over 2,000 units per year. . As of March 2013, North America dominates the market with nearly 40% share, followed by Europe due to technological developments for effective diagnostics and rapidly aging population. However, Asia is slated to grow at a high CAGR of 5.2% over the analysis period. Improved spending capability and physicians inclination towards MR imaging over other conventional medical imaging modalities is fuelling demand for MRI across this region. Asia holds enormous growth potential, particularly from countries with large population base such as China and India. The demand is anticipated primarily from private hospitals compared to public hospitals. The adoption of MR imaging equipment market is also likely to grow owing to the rising incidences of cardiac diseases, neurological and oncological cases in the region. Liquid helium, which has an extremely low boiling point of minus 452.07?F, is used for cooling the superconducting magnets of MR systems. A severe shortage in the availability of helium across the globe would affect significantly for MR OEMs. The prices for hospital-grade helium are anticipated to rise from 2013, leading to higher health-care costs or, in the worst scenario, the need for an alternative technique for cooling MRI machines. Moreover, changing healthcare reforms from early 2013 in the U.S. also resulted in 20-25% reimbursement cuts for MRI, affecting the global clinical OEMS, physicians and healthcare payers. Nevertheless, once market barriers of tight R&D budgets, high costs of MRI scans and alternate cooling systems are resolved, the industry is expected to grow considerably. With technology developers exploring many new applications, especially those involving cardiac and breast imaging, it was inevitable that magnetic resonance imaging would evolve into a highly sophisticated medical imaging tool. Scope of the Report Architecture - Closed systems - Open systems Field Strength - Low field strength systems - Mid field strength systems - High field strength systems Technology - MR Angiogram - MR Venogram - Functional MRI - MR Spectroscopy - Others -Fusion MR Application - Whole Body MRI systems - Interventional MRI systems - MRI for Brain and Neurological disorder - Breast MRI systems - Cardiac MRI systems - MR systems for Other applications such as -;Chest,Neck, Upper and Lower extremities Companies Mentioned - Advanced Imaging Research, Inc. Dba Sree Medical Systems - Agilent Technologies, Inc. - Asg Superconductors S.P.A. - Aurora Imaging Technology - Bartington Instruments, Ltd. - Bayer Healthcare Pharmaceuticals - Biophan Technologies, Inc. - Bruker Biospin Gmbh - Doty Scientific, Inc. - Esaote S.P.A - Fonar Corporation - Ge Healthcare - Hitachi Medical Corporation - Imris, Inc. - Insightec Ltd. - Lmt Lammers Medical Technology Gmbh - Mr Instruments, Inc. - Philips Healthcare - Shenzhen Basda Medical Apparatus Co. Ltd. - Siemens Healthcare - Time Medical Systems - Toshiba Medical Systems Corporation For more information visit http://www.researchandmarkets.com/research/dg...dvances_in
A: 41.57 (+0.12), IMRS: 0.22 (-0.05), SI: 132.66 (-1.58)
Nanotechnology Drug Delivery Market in the US 2012-2016 with Celgene Corp., Novartis AG and SkyePharma plc. Dominating
M2 - Wed Mar 12, 11:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3r7bw6/nanotechnology) has announced the addition of the "Nanotechnology Drug Delivery Market in the US 2012-2016" report to their offering. The analysts forecast the Nanotechnology Drug Delivery market in the US to grow at a CAGR of 84.79 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R and D cost. The Nanotechnology Drug Delivery market in the US has also been witnessing the trend of emergence of personalized medicines. However, the increasing safety concerns could pose a challenge to the growth of this market. Key vendors dominating this space include Alkermes plc., Celgene Corp., Novartis AG and SkyePharma plc. Other vendors mentioned in the report are Merck and Co. Inc., Pfizer Inc., AlphaRx Inc., Amgen, Inc., Angiotech Pharmaceuticals, Inc., Biophan Technologies, Inc., Calando Pharmaceuticals, Inc., Cephalon, Inc., Cerulean Pharma, Inc, Copernicus Therapeutics, Inc., CritiTech, Inc., CytImmune Sciences, Inc., Elan Corporation, plc, Debiotech SA, F. Hoffmann-La Roche Ltd, Nano Interface Technology, Inc, Spherics, Inc., Spectrum Pharmaceuticals, Inc., SoluBest Ltd., Sigma-Tau Pharmaceuticals, Inc., PharmaNova Inc. Particle Sciences, Inc., Novavax, Inc., Nanotherapeutics, Inc., NanoSight Ltd., NanoCarrier Co. Ltd., NanoBioMagnetics, Inc., Nano Interface Technology, Inc, Merck Sharp and Dohme Corp., Kuecept Ltd., Izon Science Ltd. Commenting on the report, an analyst from the Healthcare team said: 'Over the years, the research activities in healthcare have changed significantly. There has been a paradigm shift away from blockbusters drugs to a more personalized medicine approach. The focus is being placed increasingly on formulating drugs based on the individual's unique genome and immune response. Personalized medicines have gained significant popularity because they enable the medical profession to provide customized treatment to patients. A customized treatment is based on the genetic as well as medical profile of a patient. Increasing knowledge about the molecular causes of diseases is increasing the demand for more targeted and effective nanotechnology-enabled drug delivery therapies.' For more information visit http://www.researchandmarkets.com/research/3r...technology About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
NVAX: 5.28 (+0.09), PFE: 30.34 (-0.08), MRK: 59.07 (-0.47), AMGN: 157.68 (-3.17), SPPI: 7.21 (-0.04), ALKS: 51.47 (-1.75), NVS: 93.95 (-0.43), CELGZ: 3.28 (+0.10)
Global Advances in Magnetic Resonance Imaging (MRI) System Market Report, 2018
M2 - Mon Sep 02, 10:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d373np/advances_in) has announced the addition of the "Global Advances in Magnetic Resonance Imaging (MRI) System Market Report, 2018" report to their offering. The global MR Imaging market is estimated to be $4.13 billion, as of March 2013; it is poised to grow at a CAGR of 4.56% to reach approximately around $5.24 billion by 2018. Magnetic resonance imaging (MRI) is a noninvasive technology that exploits the use of magnetic fields and radio waves to generate anatomical images of the body. Technological advancements have led to innovations in MRI systems such as open MRI, high field strength MR systems, and dedicated MRI machines for wide range of applications in fields of oncology, neurology, and cardiology. Currently, research is being carried out to combine MR machines with other imaging modalities for achieving better image clarity. Though these dual modality MR imaging systems are still in the realm of research, they offer a great scope for medical diagnosis in the near future. A major advantage of MR Imaging is that it does not use any ionizing radiation, unlike conventional imaging. Magnetic resonance imaging is non-invasive and offers exquisite clinical images, both functionally and anatomically, with better contrast of soft tissues and anatomical structures. Many diseases such as brain tumors and breast tumors are more readily apparent in MR images than CT or other conventional imaging modalities. This market research report evaluates the global market of magnetic resonance imaging by architecture, field strength, technology, application, and geography. The market by architecture is further categorized as closed and open MRI systems; the field strength segment comprises low to mid-field strength, high field strength and very-high field strength MR systems, while the technology segment is classified as MR Angiogram, MR Venogram, functional MRI, MR Spectroscopy and Fusion MR. In addition, the application segment covers breast MRI, cardiac MRI, interventional MRI, whole body MRI and MRI for brain, and neurological disorders. Key Topics Covered: 1 Introduction 2 Executive Summary 3 MRI - Technology Snapshot 4 MRI- Value Chain Analysis 5 MRI- Market Landscape Analysis 6 Technology Adoption & Development Potential-Based On Geography 7 Regulatory Landscape Analysis 8 Reimbursement Scenario 9 Investment Analysis And Opportunities 10 Competitive Landscape Analysis 11 Patent Analysis 12 Key Company Profiles 13 Appendix Companies Mentioned - Advanced Imaging Research, IncDba Sree Medical Systems - Agilent Technologies, Inc - Asg Superconductors SPA - Aurora Imaging Technology - Bartington Instruments, Ltd - Bayer Healthcare Pharmaceuticals - Biophan Technologies, Inc - Bruker Biospin Gmbh - Doty Scientific, Inc - Esaote SPA - Fonar Corporation - Ge Healthcare - Hitachi Medical Corporation - IMRIs, Inc - Insightec Ltd - Lmt Lammers Medical Technology Gmbh - Mr Instruments, Inc - Philips Healthcare - Shenzhen Basda Medical Apparatus CoLtd - Siemens Healthcare - Time Medical Systems - Toshiba Medical Systems Corporation For more information visit http://www.researchandmarkets.com/research/d3...dvances_in
A: 41.57 (+0.12), IMRS: 0.22 (-0.05), SI: 132.66 (-1.58)
Global Interventional Cardiology Devices - Market Growth Analysis, 2009-2015
M2 - Wed Jun 26, 5:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cthfch/global) has announced the addition of the Global Interventional Cardiology Devices - Market Growth Analysis, 2009-2015 report to their offering. The broad health care' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead. Global interventional cardiac devices industry forecasts to reach at US$15.7 billion by 2015 at a high CAGR of 9.9% during the analysis period 2009-2015. The North American segment accounts for nearly 35% of the global value while Europe claims nearly 25% of the market. Asia-Pacific is the fastest growing region with a CAGR of 11.9% driving a market value of US$5 billion by 2015. On a global scale, projections for drug
BSX: 13.36 (-0.05), MDT: 68.95 (-0.43), CRDC: 0.86 (-0.01)
Global Nanotechnology Drug Delivery Market Report 2013-2016: Market to Grow at a CAGR of 74% over 2012-2016
M2 - Thu Jun 13, 9:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pg3gn5/global) has announced the addition of the "Global Nanotechnology Drug Delivery Market 2012-2016" report to their offering. IOTA NanoSolutions Ltd., Lena Nanoceutics Ltd., GlaxoSmithKline plc, Celgene Corp., and SkyePharma plc Dominate the Market Global Nanotechnology Drug Delivery market to grow at a CAGR of 73.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R&D cost. The Global Nanotechnology Drug Delivery market has also been witnessing an increase in customer support services. However, the increasing safety concerns could pose a challenge to the growth of this market. The other vendors mentioned in the report are Merck & Co. Inc., Pfizer Inc., AlphaRx Inc., Amgen Inc., Angiotech Pharmaceuticals Inc., Biophan Technologies Inc., Calando Pharmaceuticals Inc., Cephalon Inc., Cerulean Pharma Inc., Copernicus Therapeutics Inc., CritiTech Inc., CytImmune Sciences Inc., Elan Corp.
NVAX: 5.28 (+0.09), PFE: 30.34 (-0.08), MRK: 59.07 (-0.47), AMGN: 157.68 (-3.17), SPPI: 7.21 (-0.04), GSK: 45.74 (+0.08), CELGZ: 3.28 (+0.10)
Interventional Cardiology Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
M2 - Mon May 20, 6:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9pf3xp/interventional) has announced the addition of the Interventional Cardiology Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015 report to their offering. BRICSS Market Watch: The broad health care' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead. BRICSS interventional cardiology devices market forecasts to reach at US$3.2 billion by 2015 at a CAGR of 11.3% during the analysis period 2009-2015. China accounts for nearly 30% of the global value and India claims around 25% of the market. In terms of CAGR, India and China are the fastest growing regions while South Korea and Russia are just
BSX: 13.36 (-0.05), MDT: 68.95 (-0.43), CRDC: 0.86 (-0.01)
Advances in Magnetic Resonance Imaging (MRI) System Market (2013-2018)
M2 - Fri May 03, 8:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hml6fc/advances_in) has announced the addition of the "Advances in Magnetic Resonance Imaging (MRI) System Market (2013-2018) - Technology Trend Analysis - By Architecture, Field Strengths, Technology & Applications in Medical Diagnostics with Market Landscape Analysis - Estimates up to 2018" report to their offering. The research service on Advances in MRI Systems Market (2013-2018) - Technology Trend Analysis - By Architecture, Field Strengths, Technology and Applications in Medical Diagnostics with Market Landscape Analysis - Estimates up to 2018, is an attempt to showcase the technology and market impact of existing and emerging MR systems having a huge growth potential in medical imaging for the coming five years. Magnetic resonance imaging (MRI) is a medical imaging technique that makes use of magnetism, radio waves, and a computer to produce images of body structures. MRI scans have a wide variety of applications in disease diagnosis
A: 41.57 (+0.12), IMRS: 0.22 (-0.05), SI: 132.66 (-1.58)
Cardiac Rhythm Management (CRM) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
M2 - Tue Apr 30, 4:26AM CDT
Research and Markets has announced the addition of the "Cardiac Rhythm Management (CRM) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015" report to their offering. The report Cardiac Rhythm Management (CRM) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa and South Korea), 2009-2015' reviews the latest trends in the CRM devices market with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations. The period considered for the market analysis is 2009-2015. The region wise distribution of the market consists of Emerging Markets Brazil, Russia, India, China, South Africa and South Korea. I
BSX: 13.36 (-0.05), MDT: 68.95 (-0.43), CRDC: 0.86 (-0.01)
Global Cardiac Defibrillators Market Forecasts to Reach at US$10.5 Billion by 2015 at A CAGR Of 8.6% Says Latest Report
M2 - Tue Apr 23, 11:05AM CDT
Research and Markets has announced the addition of the "Global Cardiac Defibrillators - Market Growth Analysis, 2009-2015" report to their offering. Global Market Watch: The broad health care' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead. Global Cardiac Defibrillators market forecasts to reach at US$10.5 billion by 2015 at a CAGR of 8.6% during the analysis period 2009-2015. The North American segment accounts for nearly 40% of the global value while Europe claims approximately 30% of the market. Asia-Pacific is the fastest growing region with a CAGR of 10.3% driving a market value of US$2.6 billion by 2015. On a global scale, projections for External Defibrillators market value indicate less than ha
BSX: 13.36 (-0.05), MDT: 68.95 (-0.43), CRDC: 0.86 (-0.01)
The Nanotechnology Drug Delivery Market in the US to Grow At A CAGR Of 84.79 Percent over the Period 2012-2016
M2 - Mon Apr 08, 1:16PM CDT
Research and Markets has announced the addition of the "Nanotechnology Drug Delivery Market in the US 2012-2016" report to their offering. One of the key factors contributing to this market growth is the low R and D cost. The Nanotechnology Drug Delivery market in the US has also been witnessing the trend of emergence of personalized medicines. However, the increasing safety concerns could pose a challenge to the growth of this market. Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Over the years, the research activities in healthcare have changed significantly. There has been a paradigm shift away from blockbusters drugs to a more personalized medicine approach. The focus is being placed increasingly on formulating drugs based on the individual's unique genome and immune response. Personalized medicines have gained significant popularity because they enable the medical profession to provide customized treatment to patients. A customized treatment is based on the genetic as
PFE: 30.34 (-0.08), AMGN: 157.68 (-3.17), SPPI: 7.21 (-0.04), GSK: 45.74 (+0.08), ALKS: 51.47 (-1.75), NVAX: 5.28 (+0.09), MRK: 59.07 (-0.47), CELGZ: 3.28 (+0.10), NVS: 93.95 (-0.43)
Global Nanotechnology Drug Delivery Market 2012-2016: IOTA NanoSolutions Ltd., Lena Nanoceutics Ltd., GlaxoSmithKline plc, Celgene Corp., and SkyePharma Dominate the Market
M2 - Tue Mar 26, 10:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4xvp3b/global) has announced the addition of the "Global Nanotechnology Drug Delivery Market 2012-2016" report to their offering. TechNavio's analysts forecast the Global Nanotechnology Drug Delivery market to grow at a CAGR of 73.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R&D cost. The Global Nanotechnology Drug Delivery market has also been witnessing an increase in customer support services. However, the increasing safety concerns could pose a challenge to the growth of this market. Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Pharmaceutical and biotechnology companies are focusing on capitalizing on the potential of nanotechnology-enabled drug delivery. Nanotechnology-enabled drug delivery systems are helping pharmaceutical and biotechnology companies to counter the threat of generics. Reformulation helps in extending the product life cycle,
NVAX: 5.28 (+0.09), PFE: 30.34 (-0.08), MRK: 59.07 (-0.47), AMGN: 157.68 (-3.17), SPPI: 7.21 (-0.04), GSK: 45.74 (+0.08), CELGZ: 3.28 (+0.10)
Advances in MRI System Market 2013-2018: Architecture, Field Strengths, Technology & Applications in Medical Diagnostics with Market Landscape Analysis
M2 - Tue Aug 19, 6:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xpmg9p/advances_in) has announced the addition of the "Advances in Magnetic Resonance Imaging (MRI) System Market (2013-2018) - Technology Trend Analysis - By Architecture, Field Strengths, Technology & Applications in Medical Diagnostics with Market Landscape Analysis - Estimates up to 2018" report to their offering. The global MR Imaging market is estimated to be $4.13 billion, as of March 2013; it is poised to grow at a CAGR of 4.56% to reach approximately around $5.24 billion by 2018 This market research report evaluates the global market of magnetic resonance imaging by architecture, field strength, technology, application, and geography. The market by architecture is further categorized as closed and open MRI systems; the field strength segment comprises low to mid-field strength, high field strength and very-high field strength MR systems, while the technology segment is classified as MR Angiogram, MR Venogram, functional MRI, MR Spectroscopy and Fusion MR. In addition, the application segment covers breast MRI, cardiac MRI, interventional MRI, whole body MRI and MRI for brain, and neurological disorders. This research report covers in-depth market analysis of MR imaging based on architecture - open and closed systems providing market dynamics and opportunities for the coming five years. Closed systems account for the largest share of the total market in 2013. However open MR systems are anticipated to witness a high growth rate owing to rising demand by physician for claustrophobic and elder patients. The increasing applications in the field of angiography, cancer screening, breast screening, and neurology would certainly foster the growth of the market. Functional MRI remains a significant market, due to increasing number of research to study the human brain and brain disorders across the universities world-wide. Key players in the market include GE Healthcare (U.K.), Hitachi Medical Systems (Japan), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), and Toshiba Medical Systems (Japan). The report profiles around 22 companies - leading magnet systems and RF coil manufacturers to clinical OEMs. Scope of the Report By Architecture - Closed systems - Open systems By Field Strength - Low field strength systems - Mid field strength systems - High field strength systems By Technology - MR Angiogram - MR Venogram - Functional MRI - MR Spectroscopy - Others -Fusion MR By Application - Whole Body MRI systems - Interventional MRI systems - MRI for Brain and Neurological disorder - Breast MRI systems - Cardiac MRI systems - MR systems for Other applications such as -;Chest,Neck, Upper and Lower extremities Companies Featured - Advanced Imaging Research, Inc. DBA Sree Medical Systems - Agilent Technologies, Inc. - ASG Superconductors S.P.A. - Aurora Imaging Technology - Bartington Instruments, Ltd. - Bayer Healthcare Pharmaceuticals - Biophan Technologies, Inc. - Bruker Biospin Gmbh - Doty Scientific, Inc. - Esaote S.P.A - Fonar Corporation - Ge Healthcare - Hitachi Medical Corporation - IMRIs, Inc. - Insightec Ltd. - LMT Lammers Medical Technology Gmbh - MR Instruments, Inc. - Philips Healthcare - Shenzhen Basda Medical Apparatus Co. Ltd. - Siemens Healthcare - Time Medical Systems - Toshiba Medical Systems Corporation For more information visit http://www.researchandmarkets.com/research/xp...dvances_in
A: 41.57 (+0.12), IMRS: 0.22 (-0.05)
Peripheral Vascular Devices - Global Trends, Estimates and Forecasts, 2012-2018
M2 - Tue Aug 05, 4:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/34vckj/peripheral) has announced the addition of the "Peripheral Vascular Devices - Global Trends, Estimates and Forecasts, 2012-2018" report to their offering. Global Peripheral Vascular Devices sector forecasts to reach US$5 billion by 2016 at a CAGR of 10.8% during the analysis period 2012-2018. North American region accounts for highest percentage approximately 42% (2015) of global share while Europe follows next with nearly 27.7% (2018) of the market. Asia-Pacific is the fastest growing region with a CAGR of 12.5% driving a market value of US$1 billion by 2015. On a global scale, projections for Peripheral Vascular Stents market value indicate nearly 36% by 2015 leaving the rest of the market to the Vascular Closure Devices, AAA Stent Grafts, Inferior Vena Cava (IVC) Filters)etc. Geographical analysis for Peripheral Guidewires market shows that the highest Compounded Annual Growth Rate (CAGR) of 13.8% is anticipated from Asia-Pacific region during the analysis period 2012-2018. Europe follows Asia-Pacific with a CAGR of 12.7% while the North America forecasts to drive with a growth rate of 10.8%. Companies Mentioned: - Abbott Vascular Devices - Abiomed, Inc. - Accellent, Inc. - Accutech, Llc - Advansource Biomaterials Corporation - Aerotel Medical Systems, Ltd. - Alere, Inc. - All Pro Corporation - Ambu A/S - Angiodynamics, Inc. - Aortech International, Plc. - Apc Cardiovascular, Ltd. - Aptus Endosystems, Inc. - Arterial Remodeling Technologiesuscome Limited - Asahi Intecc Co., Ltd. - Asahi Kasei Corporation - Ash Access Technology, Inc. - Asian Heart Institute - Atcor Medical Holdings Limited - Atricure, Inc. - Atrium Medical Corporation - Baxter International Inc. - Becton, Dickinson & Co. - Beijing Anzhen Hospital - Berlin Heart Gmbh - Bioclinica - Bioheart, Inc. - Biophan Technologies, Inc. - Biosense Webster, Inc. - Dr?ger Medical Ag & Co. Kg - Edwards Lifesciences, Llc. - Endologix Incorporated - Esaote S.P.A - Fleming Medical Limited - Fluxion - Fudan University Zhongshan Hospital - Fukuda Denshi Co., Ltd. - Gamida Cell Ltd. - Ge Healthcare - Goodman Co., Ltd. - Greatbatch, Inc. - Heartware Ltd. - Hospira, Inc. - Volcano Corporation - 3M Healthcare For more information visit http://www.researchandmarkets.com/research/34vckj/peripheral
BDX: 129.20 (-0.11), GB: 49.57 (-0.10), EW: 124.50 (-0.05), ALR: 40.00 (-0.01), ELGX: 11.48 (-0.21), BAX: 71.75 (-0.33), VOLC: 10.92 (+0.13)
Magnetic Resonance Imaging (MRI) System Advances Market Forecasts & Opportunities, 2018
M2 - Tue Mar 25, 10:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dgsl45/advances_in) has announced the addition of the "Magnetic Resonance Imaging (MRI) System Advances Market Forecasts & Opportunities, 2018" report to their offering. The global market for these systems values $4.13 billion, as of the first quarter of 2013, and is expected to grow at a CAGR of 4.56% reaching approximately around $5.24 billion by 2018 The current magnetic resonance imaging industry is producing over 2,000 units per year. . As of March 2013, North America dominates the market with nearly 40% share, followed by Europe due to technological developments for effective diagnostics and rapidly aging population. However, Asia is slated to grow at a high CAGR of 5.2% over the analysis period. Improved spending capability and physicians inclination towards MR imaging over other conventional medical imaging modalities is fuelling demand for MRI across this region. Asia holds enormous growth potential, particularly from countries with large population base such as China and India. The demand is anticipated primarily from private hospitals compared to public hospitals. The adoption of MR imaging equipment market is also likely to grow owing to the rising incidences of cardiac diseases, neurological and oncological cases in the region. Liquid helium, which has an extremely low boiling point of minus 452.07?F, is used for cooling the superconducting magnets of MR systems. A severe shortage in the availability of helium across the globe would affect significantly for MR OEMs. The prices for hospital-grade helium are anticipated to rise from 2013, leading to higher health-care costs or, in the worst scenario, the need for an alternative technique for cooling MRI machines. Moreover, changing healthcare reforms from early 2013 in the U.S. also resulted in 20-25% reimbursement cuts for MRI, affecting the global clinical OEMS, physicians and healthcare payers. Nevertheless, once market barriers of tight R&D budgets, high costs of MRI scans and alternate cooling systems are resolved, the industry is expected to grow considerably. With technology developers exploring many new applications, especially those involving cardiac and breast imaging, it was inevitable that magnetic resonance imaging would evolve into a highly sophisticated medical imaging tool. Scope of the Report Architecture - Closed systems - Open systems Field Strength - Low field strength systems - Mid field strength systems - High field strength systems Technology - MR Angiogram - MR Venogram - Functional MRI - MR Spectroscopy - Others -Fusion MR Application - Whole Body MRI systems - Interventional MRI systems - MRI for Brain and Neurological disorder - Breast MRI systems - Cardiac MRI systems - MR systems for Other applications such as -;Chest,Neck, Upper and Lower extremities Companies Mentioned - Advanced Imaging Research, Inc. Dba Sree Medical Systems - Agilent Technologies, Inc. - Asg Superconductors S.P.A. - Aurora Imaging Technology - Bartington Instruments, Ltd. - Bayer Healthcare Pharmaceuticals - Biophan Technologies, Inc. - Bruker Biospin Gmbh - Doty Scientific, Inc. - Esaote S.P.A - Fonar Corporation - Ge Healthcare - Hitachi Medical Corporation - Imris, Inc. - Insightec Ltd. - Lmt Lammers Medical Technology Gmbh - Mr Instruments, Inc. - Philips Healthcare - Shenzhen Basda Medical Apparatus Co. Ltd. - Siemens Healthcare - Time Medical Systems - Toshiba Medical Systems Corporation For more information visit http://www.researchandmarkets.com/research/dg...dvances_in
A: 41.57 (+0.12), IMRS: 0.22 (-0.05), SI: 132.66 (-1.58)
Nanotechnology Drug Delivery Market in the US 2012-2016 with Celgene Corp., Novartis AG and SkyePharma plc. Dominating
M2 - Wed Mar 12, 11:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3r7bw6/nanotechnology) has announced the addition of the "Nanotechnology Drug Delivery Market in the US 2012-2016" report to their offering. The analysts forecast the Nanotechnology Drug Delivery market in the US to grow at a CAGR of 84.79 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R and D cost. The Nanotechnology Drug Delivery market in the US has also been witnessing the trend of emergence of personalized medicines. However, the increasing safety concerns could pose a challenge to the growth of this market. Key vendors dominating this space include Alkermes plc., Celgene Corp., Novartis AG and SkyePharma plc. Other vendors mentioned in the report are Merck and Co. Inc., Pfizer Inc., AlphaRx Inc., Amgen, Inc., Angiotech Pharmaceuticals, Inc., Biophan Technologies, Inc., Calando Pharmaceuticals, Inc., Cephalon, Inc., Cerulean Pharma, Inc, Copernicus Therapeutics, Inc., CritiTech, Inc., CytImmune Sciences, Inc., Elan Corporation, plc, Debiotech SA, F. Hoffmann-La Roche Ltd, Nano Interface Technology, Inc, Spherics, Inc., Spectrum Pharmaceuticals, Inc., SoluBest Ltd., Sigma-Tau Pharmaceuticals, Inc., PharmaNova Inc. Particle Sciences, Inc., Novavax, Inc., Nanotherapeutics, Inc., NanoSight Ltd., NanoCarrier Co. Ltd., NanoBioMagnetics, Inc., Nano Interface Technology, Inc, Merck Sharp and Dohme Corp., Kuecept Ltd., Izon Science Ltd. Commenting on the report, an analyst from the Healthcare team said: 'Over the years, the research activities in healthcare have changed significantly. There has been a paradigm shift away from blockbusters drugs to a more personalized medicine approach. The focus is being placed increasingly on formulating drugs based on the individual's unique genome and immune response. Personalized medicines have gained significant popularity because they enable the medical profession to provide customized treatment to patients. A customized treatment is based on the genetic as well as medical profile of a patient. Increasing knowledge about the molecular causes of diseases is increasing the demand for more targeted and effective nanotechnology-enabled drug delivery therapies.' For more information visit http://www.researchandmarkets.com/research/3r...technology About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
NVAX: 5.28 (+0.09), PFE: 30.34 (-0.08), MRK: 59.07 (-0.47), AMGN: 157.68 (-3.17), SPPI: 7.21 (-0.04), ALKS: 51.47 (-1.75), NVS: 93.95 (-0.43), CELGZ: 3.28 (+0.10)
Global Advances in Magnetic Resonance Imaging (MRI) System Market Report, 2018
M2 - Mon Sep 02, 10:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d373np/advances_in) has announced the addition of the "Global Advances in Magnetic Resonance Imaging (MRI) System Market Report, 2018" report to their offering. The global MR Imaging market is estimated to be $4.13 billion, as of March 2013; it is poised to grow at a CAGR of 4.56% to reach approximately around $5.24 billion by 2018. Magnetic resonance imaging (MRI) is a noninvasive technology that exploits the use of magnetic fields and radio waves to generate anatomical images of the body. Technological advancements have led to innovations in MRI systems such as open MRI, high field strength MR systems, and dedicated MRI machines for wide range of applications in fields of oncology, neurology, and cardiology. Currently, research is being carried out to combine MR machines with other imaging modalities for achieving better image clarity. Though these dual modality MR imaging systems are still in the realm of research, they offer a great scope for medical diagnosis in the near future. A major advantage of MR Imaging is that it does not use any ionizing radiation, unlike conventional imaging. Magnetic resonance imaging is non-invasive and offers exquisite clinical images, both functionally and anatomically, with better contrast of soft tissues and anatomical structures. Many diseases such as brain tumors and breast tumors are more readily apparent in MR images than CT or other conventional imaging modalities. This market research report evaluates the global market of magnetic resonance imaging by architecture, field strength, technology, application, and geography. The market by architecture is further categorized as closed and open MRI systems; the field strength segment comprises low to mid-field strength, high field strength and very-high field strength MR systems, while the technology segment is classified as MR Angiogram, MR Venogram, functional MRI, MR Spectroscopy and Fusion MR. In addition, the application segment covers breast MRI, cardiac MRI, interventional MRI, whole body MRI and MRI for brain, and neurological disorders. Key Topics Covered: 1 Introduction 2 Executive Summary 3 MRI - Technology Snapshot 4 MRI- Value Chain Analysis 5 MRI- Market Landscape Analysis 6 Technology Adoption & Development Potential-Based On Geography 7 Regulatory Landscape Analysis 8 Reimbursement Scenario 9 Investment Analysis And Opportunities 10 Competitive Landscape Analysis 11 Patent Analysis 12 Key Company Profiles 13 Appendix Companies Mentioned - Advanced Imaging Research, IncDba Sree Medical Systems - Agilent Technologies, Inc - Asg Superconductors SPA - Aurora Imaging Technology - Bartington Instruments, Ltd - Bayer Healthcare Pharmaceuticals - Biophan Technologies, Inc - Bruker Biospin Gmbh - Doty Scientific, Inc - Esaote SPA - Fonar Corporation - Ge Healthcare - Hitachi Medical Corporation - IMRIs, Inc - Insightec Ltd - Lmt Lammers Medical Technology Gmbh - Mr Instruments, Inc - Philips Healthcare - Shenzhen Basda Medical Apparatus CoLtd - Siemens Healthcare - Time Medical Systems - Toshiba Medical Systems Corporation For more information visit http://www.researchandmarkets.com/research/d3...dvances_in
A: 41.57 (+0.12), IMRS: 0.22 (-0.05), SI: 132.66 (-1.58)
Global Interventional Cardiology Devices - Market Growth Analysis, 2009-2015
M2 - Wed Jun 26, 5:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cthfch/global) has announced the addition of the Global Interventional Cardiology Devices - Market Growth Analysis, 2009-2015 report to their offering. The broad health care' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead. Global interventional cardiac devices industry forecasts to reach at US$15.7 billion by 2015 at a high CAGR of 9.9% during the analysis period 2009-2015. The North American segment accounts for nearly 35% of the global value while Europe claims nearly 25% of the market. Asia-Pacific is the fastest growing region with a CAGR of 11.9% driving a market value of US$5 billion by 2015. On a global scale, projections for drug
BSX: 13.36 (-0.05), MDT: 68.95 (-0.43), CRDC: 0.86 (-0.01)
Global Nanotechnology Drug Delivery Market Report 2013-2016: Market to Grow at a CAGR of 74% over 2012-2016
M2 - Thu Jun 13, 9:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pg3gn5/global) has announced the addition of the "Global Nanotechnology Drug Delivery Market 2012-2016" report to their offering. IOTA NanoSolutions Ltd., Lena Nanoceutics Ltd., GlaxoSmithKline plc, Celgene Corp., and SkyePharma plc Dominate the Market Global Nanotechnology Drug Delivery market to grow at a CAGR of 73.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R&D cost. The Global Nanotechnology Drug Delivery market has also been witnessing an increase in customer support services. However, the increasing safety concerns could pose a challenge to the growth of this market. The other vendors mentioned in the report are Merck & Co. Inc., Pfizer Inc., AlphaRx Inc., Amgen Inc., Angiotech Pharmaceuticals Inc., Biophan Technologies Inc., Calando Pharmaceuticals Inc., Cephalon Inc., Cerulean Pharma Inc., Copernicus Therapeutics Inc., CritiTech Inc., CytImmune Sciences Inc., Elan Corp.
NVAX: 5.28 (+0.09), PFE: 30.34 (-0.08), MRK: 59.07 (-0.47), AMGN: 157.68 (-3.17), SPPI: 7.21 (-0.04), GSK: 45.74 (+0.08), CELGZ: 3.28 (+0.10)
Interventional Cardiology Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
M2 - Mon May 20, 6:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9pf3xp/interventional) has announced the addition of the Interventional Cardiology Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015 report to their offering. BRICSS Market Watch: The broad health care' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead. BRICSS interventional cardiology devices market forecasts to reach at US$3.2 billion by 2015 at a CAGR of 11.3% during the analysis period 2009-2015. China accounts for nearly 30% of the global value and India claims around 25% of the market. In terms of CAGR, India and China are the fastest growing regions while South Korea and Russia are just
BSX: 13.36 (-0.05), MDT: 68.95 (-0.43), CRDC: 0.86 (-0.01)
Advances in Magnetic Resonance Imaging (MRI) System Market (2013-2018)
M2 - Fri May 03, 8:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hml6fc/advances_in) has announced the addition of the "Advances in Magnetic Resonance Imaging (MRI) System Market (2013-2018) - Technology Trend Analysis - By Architecture, Field Strengths, Technology & Applications in Medical Diagnostics with Market Landscape Analysis - Estimates up to 2018" report to their offering. The research service on Advances in MRI Systems Market (2013-2018) - Technology Trend Analysis - By Architecture, Field Strengths, Technology and Applications in Medical Diagnostics with Market Landscape Analysis - Estimates up to 2018, is an attempt to showcase the technology and market impact of existing and emerging MR systems having a huge growth potential in medical imaging for the coming five years. Magnetic resonance imaging (MRI) is a medical imaging technique that makes use of magnetism, radio waves, and a computer to produce images of body structures. MRI scans have a wide variety of applications in disease diagnosis
A: 41.57 (+0.12), IMRS: 0.22 (-0.05), SI: 132.66 (-1.58)
Cardiac Rhythm Management (CRM) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
M2 - Tue Apr 30, 4:26AM CDT
Research and Markets has announced the addition of the "Cardiac Rhythm Management (CRM) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015" report to their offering. The report Cardiac Rhythm Management (CRM) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa and South Korea), 2009-2015' reviews the latest trends in the CRM devices market with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations. The period considered for the market analysis is 2009-2015. The region wise distribution of the market consists of Emerging Markets Brazil, Russia, India, China, South Africa and South Korea. I
BSX: 13.36 (-0.05), MDT: 68.95 (-0.43), CRDC: 0.86 (-0.01)
Global Cardiac Defibrillators Market Forecasts to Reach at US$10.5 Billion by 2015 at A CAGR Of 8.6% Says Latest Report
M2 - Tue Apr 23, 11:05AM CDT
Research and Markets has announced the addition of the "Global Cardiac Defibrillators - Market Growth Analysis, 2009-2015" report to their offering. Global Market Watch: The broad health care' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead. Global Cardiac Defibrillators market forecasts to reach at US$10.5 billion by 2015 at a CAGR of 8.6% during the analysis period 2009-2015. The North American segment accounts for nearly 40% of the global value while Europe claims approximately 30% of the market. Asia-Pacific is the fastest growing region with a CAGR of 10.3% driving a market value of US$2.6 billion by 2015. On a global scale, projections for External Defibrillators market value indicate less than ha
BSX: 13.36 (-0.05), MDT: 68.95 (-0.43), CRDC: 0.86 (-0.01)
The Nanotechnology Drug Delivery Market in the US to Grow At A CAGR Of 84.79 Percent over the Period 2012-2016
M2 - Mon Apr 08, 1:16PM CDT
Research and Markets has announced the addition of the "Nanotechnology Drug Delivery Market in the US 2012-2016" report to their offering. One of the key factors contributing to this market growth is the low R and D cost. The Nanotechnology Drug Delivery market in the US has also been witnessing the trend of emergence of personalized medicines. However, the increasing safety concerns could pose a challenge to the growth of this market. Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Over the years, the research activities in healthcare have changed significantly. There has been a paradigm shift away from blockbusters drugs to a more personalized medicine approach. The focus is being placed increasingly on formulating drugs based on the individual's unique genome and immune response. Personalized medicines have gained significant popularity because they enable the medical profession to provide customized treatment to patients. A customized treatment is based on the genetic as
PFE: 30.34 (-0.08), AMGN: 157.68 (-3.17), SPPI: 7.21 (-0.04), GSK: 45.74 (+0.08), ALKS: 51.47 (-1.75), NVAX: 5.28 (+0.09), MRK: 59.07 (-0.47), CELGZ: 3.28 (+0.10), NVS: 93.95 (-0.43)
Global Nanotechnology Drug Delivery Market 2012-2016: IOTA NanoSolutions Ltd., Lena Nanoceutics Ltd., GlaxoSmithKline plc, Celgene Corp., and SkyePharma Dominate the Market
M2 - Tue Mar 26, 10:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4xvp3b/global) has announced the addition of the "Global Nanotechnology Drug Delivery Market 2012-2016" report to their offering. TechNavio's analysts forecast the Global Nanotechnology Drug Delivery market to grow at a CAGR of 73.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R&D cost. The Global Nanotechnology Drug Delivery market has also been witnessing an increase in customer support services. However, the increasing safety concerns could pose a challenge to the growth of this market. Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Pharmaceutical and biotechnology companies are focusing on capitalizing on the potential of nanotechnology-enabled drug delivery. Nanotechnology-enabled drug delivery systems are helping pharmaceutical and biotechnology companies to counter the threat of generics. Reformulation helps in extending the product life cycle,
NVAX: 5.28 (+0.09), PFE: 30.34 (-0.08), MRK: 59.07 (-0.47), AMGN: 157.68 (-3.17), SPPI: 7.21 (-0.04), GSK: 45.74 (+0.08), CELGZ: 3.28 (+0.10)
